Practice Fusion And AstraZeneca Partner for PHM Initiative For Asthma, COPD – Lung Disease News


Lung Disease News

Practice Fusion And AstraZeneca Partner for PHM Initiative For Asthma, COPD
Lung Disease News
The program provides data-driven insights that can assist members in their commitment to improving care for those suffering with chronic obstructive pulmonary disease (COPD) or asthma. The program is sponsored by AstraZeneca and being advanced by …
AstraZeneca and EHR firm to use drug alert systemPMLiVE

all 3 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.